Skadden, Arps has announced the return of the Federal Trade Commission’s chief trial counsel Tara Reinhart to its antitrust and competition group.
Tara Reinhart will re-join Skadden, Arps, Slate, Meagher & Flom as a partner in the Washington, DC, office where she will practice complex antitrust litigation and assist clients who are subject to international cartel, and other government, investigations, such as those commenced by the United States Department of Justice antitrust division and state attorneys general.
In addition to her investigations experience, Reinhart has defended clients against class action claims of reverse payments, price-fixing and monopolisation, as well as grand jury investigations.
She returns to private practice from the United States Federal Trade Commission where she was chief trial counsel in the Bureau of Competition for just under two years, handling federal court and administrative litigation; during which time she led the successful litigation against office supply chain store Staples over its proposed acquisition of Office Depot, one of the FTC’s most prolific merger litigation trials in over a decade.
In a statement, Skadden’s head of global antitrust and competition Steven Sunshine said: “The breadth of Tara’s merger litigation experience, along with her track record as a highly regarded antitrust litigator, will be of tremendous value to our clients.”
Full Content: CDR News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas